Biocon Founder Names Niece as Successor

Kiran Mazumdar-Shaw, the 73-year-old founder and chairperson of Biocon, has named her niece Claire Mazumdar as her successor to lead the Indian biopharmaceutical company into its next growth phase.

Mazumdar-Shaw, who has no children and serves as the sole owner of the Bengaluru-based firm founded in 1978, announced the plan in an interview published Tuesday. "I am the sole owner of Biocon, and I need to make sure that I put it in good hands," she said. "I have seen my niece Claire as my successor because I think she has proved to me that she can run a company."

Claire Mazumdar, 37, currently serves as founder and chief executive officer of Bicara Therapeutics, a Nasdaq-listed clinical-stage oncology company incubated by Biocon. She assumed the CEO role in 2018 and oversaw its public debut in 2024 at a valuation exceeding $800 million; the company's market capitalization has since surpassed $1.6 billion. Biocon holds a minority stake of about 10 percent in Bicara. Mazumdar also sits on the boards of Relay Therapeutics and Noora Health.

Her qualifications include an undergraduate degree in biological engineering from the Massachusetts Institute of Technology, a doctorate in cancer...